DNA-repair status should be assessed in treatment-emergent neuroendocrine prostate cancer before platinum-based therapy

Zhu, SM; Zhang, Z; Zhang, H; Liu, ZH; Liu, M; Liu, Q; Zang, L; Wang, LL; Ji, JP; Wu, B; Sun, LB; Zhang, ZT; Cao, HR; Wang, Y; Wang, HT; Shang, ZQ; Niu, YJ

Wang, Y; Shang, ZQ; Niu, YJ (通讯作者),Tianjin Med Univ, Tianjin Inst Urol, Dept Urol, Hosp 2, 23 Pingjiang Rd, Tianjin 300211, Peoples R China.;Wang, HT (通讯作者),Tianjin Med Univ, Tianjin Inst Urol, Dept Oncol, Hosp 2, Tianjin, Peoples R China.

PROSTATE, 2022; 82 (4): 464

Abstract

Objectives This study sought to provide contemporary data from a multi-institution with respect to DNA-repair genes (DRGs) status and its impact on ef......

Full Text Link